About Boster Biological Technology (Boster Bio)
Founded in 1993, Boster Biological Technology (Boster Bio) develops research reagents and assay products for life science laboratories. Its expertise spans antibodies, immunoassays, recombinant proteins and custom research services. The company supports studies in cell biology, immunology, oncology, neuroscience, metabolism and inflammatory disease research. Its antibody portfolio includes rabbit monoclonal, mouse monoclonal and polyclonal antibodies validated for applications such as immunohistochemistry, western blotting, ELISA and flow cytometry. Boster Bio also provides protein expression, gene synthesis and analytical testing services that help researchers investigate protein expression, biomarker function and cellular signalling pathways.
The product portfolio includes more than 40,000 antibodies, PicoKine® ELISA Kits, recombinant proteins, secondary antibodies and reagents for immunoblotting and IHC/IF workflows. Additional capabilities include custom antibody production, AAV packaging, reporter cell line development and cell-based assay services. Boster Bio supports a broad range of experimental workflows, including ELISA testing, multiplex assays, flow cytometry, histology, western blotting, compound screening and RNA in situ hybridisation studies. These tools enable researchers to quantify proteins, validate biomarkers and characterise cellular responses across basic and translational research applications.
Europa Biosite’s subsidiaries distribute for Boster Bio in Sweden and the United Kingdom.